Shanghai Shenqi Pharmaceutical's high P/E ratio is alarming ...
Shanghai Shenqi Pharmaceutical's high P/E ratio is alarming considering its recent poor earnings. The market overlooks limited growth, hoping for a business turnaround. However, without significant medium-term improvements, these prices may not hold.
More Unpleasant Surprises Could Be In Store For Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.'s (SHSE:600613) Shares After Tumbling 26%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment